The Effect of Cold Storage Solutions on Ischemic Injury in Lung Transplantation
This trial is active, not recruiting.
|Condition||lung transplant recipients|
|Treatment||celsior cold storage solution|
|Sponsor||Johns Hopkins University|
|Start date||December 2000|
|End date||September 2005|
|Trial identifier||NCT00284726, 00-10-25-03|
The purpose of this study is to compare 2 different cold storage solutions, used to preserve donor lungs for lung transplantation, and their effect on cytokine activation related to ischemic reperfusion injury. Primary endpoint is 30 day survival.
Male or female participants of any age.
Inclusion Criteria: Any patient undergoing a lung trasnplant at Johns Hopkins Hospital - Exclusion Criteria: -
|Official title||A Prospective, Controlled, Randomized Study on the Effect of Cold Storage Solutions on Complement Activation and Other Mediators of Ischemic Injury in Lung Transplantation|
|Principal investigator||John V. Conte, M.D.|
|Description||The length of ischemic time in harvesting lung allografts is associated with graft survival. It is further thought that ischemic changes in early post-transplantation bronchoscopic biopsies has a direct correlation with later development of chronic rejection.|
Call for more information